CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Natera, Inc.

NTRA
$21.83B
Large Cap
NASDAQServices-Medical LaboratoriesGenetic testing🇺🇸North AmericaAUSTIN3.0K employees

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.

Website

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

1

Next Catalyst

Aug 6, 2026

6w

Market Overview

Stock performance and key metrics

NTRA News
Catalyst Timeline

1 upcoming, 0 past

Drug Pipeline

No drugs found in this phase.

Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply